Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2006) 12 P33

SFE2006 Poster Presentations Cytokines, growth factors, growth and development (3 abstracts)

Effects of recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3) on human malignant pleural mesothelioma cell growth

F Miraki-Moud , C Martinelli & C Camacho-Hübner


William Harvey Research Institute, University of London, London, United Kingdom.


Malignant pleural mesothelioma (MPM) is an asbestos-related tumour which is highly resistant to standard treatments, thus continuing to present a therapeutically challenge. Insulin-like growth factor system (IGFs), play an important role in the regulation of solid tumour cell growth. IGFBP-3, the most abundant circulating IGF binding protein, inhibits cell growth by both IGF-I dependent and independent pathways.

The aim of our study was to evaluate the effects of rhIGFBP-3 treatment in regulating MPM cell growth in vitro.

Methods

Two MPM cells (NCI-H28 and NCI-H2052) were used. Western ligand, immunoblot analysis and PCR methods were performed to characterise the various components of the IGF system. Cell proliferation was determined by a colorimetric MTS assay, anchorage-independent growth was examined in a methylcellulose-based clonogenic assay and cytotoxicity effect of rhIGFBP-3 was assessed by clonogenic assay using crystal violet staining. Cells were treated with rhIGF-I (50–100 ng/ml), rhIGFBP-3 (0.5, 1 and 5 μg/ml) and des-IGF-I (100 ng/ml) for 24 hrs, alone or in combination.

Results

MPM cell lines express IGFBP-2, -3, and -5, IGF-I and IGF-II mRNA and secrete IGFBP-3 and IGFBP-2 in conditioned medium. RhIGF-I and des-IGF-I treatment increased MPM cell proliferation by 61% and 49%, respectively compared to serum free media (SFM, P<0.05). In contrast, rhIGFBP-3 treatment significantly decreased proliferation in NCI-H2052 cells (12%). One of the best indicators of tumorigenicity in vitro is the anchorage independence of tumour cells, which was examined using methylcellulose assay. Treatment of cells with rhIGFBP-3 markedly decreased colony formation in both MPM cell lines. We have also showed that in NCI-H2052 cell lines colony formation was significantly decreased with rhIGFBP-3 (1 μg/ml) by 30% and in NCI-H28 cell lines by 52% compared to non treated cells.

In conclusion, rhIGFBP-3 decreased proliferation and tumorigenicity in MPM cells in vitro.

Volume 12

197th Meeting of the Society for Endocrinology

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.